Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MME | P08473 | 5/20 | 0.42 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27651567 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MMECNR1TAS1R3TAS1R1 | |
| SCHEMBL25291547 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MMECNR1TAS1R3TAS1R1 | |
| Benzene SCHEMBL28850626 | 0.96 | CNR1 (0.43) | ALDH1A1MMECNR1TAS1R3TAS1R1 | |
| SCHEMBL15872915 | 0.84 | TRPA1 (0.39) | ALDH1A1MMECNR1CYP2D6CYP2C19 | |
| SCHEMBL16515196 | 0.84 | TRPA1 (0.39) | ALDH1A1MMECNR1CYP2D6CYP2C19 | |
| SCHEMBL16515197 | 0.84 | TRPA1 (0.39) | ALDH1A1MMECNR1CYP2D6CYP2C19 | |
| SCHEMBL4341862 | 0.84 | TAS1R3 (0.42) | ALDH1A1MMECNR1TAS1R3TAS1R1 | |
| SCHEMBL26965341 | 0.83 | PLA2G10 (0.42) | ALDH1A1MMETAS1R3TAS1R1MEN1 | |
| SCHEMBL27120254 | 0.83 | PLA2G10 (0.42) | ALDH1A1MMETAS1R3TAS1R1MEN1 | |
| SCHEMBL14294441 | 0.82 | ALDH1A1 (0.52) | ALDH1A1MMECNR1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230406860-A1 | HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE | AMGEN INC. | 2023-12-21 | — | — | US | disclosed |
| US-20230219975-A1 | PYRIDO[2,3-B][1,4]OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4]OXAZEPINES AS IAP ANTAGONISTS | BEONE MEDICINES I GMBH (CH) | 2023-07-13 | — | — | US | disclosed |
| US-20210277001-A1 | BIARYL KINASE INHIBITORS | Cosmic Pet LLC | 2021-09-09 | — | — | US | disclosed |
| US-10981910-B2 | Biaryl kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200317671-A1 | BIARYL KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-10-08 | — | — | US | disclosed |
| US-10723734-B2 | Biaryl kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-07-28 | — | — | US | disclosed |
| US-10544120-B2 | Biaryl kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-01-28 | — | — | US | disclosed |
| US-10351563-B2 | Biaryl kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-07-16 | — | — | US | disclosed |
| EP-3292124-B1 | 6H-ISOCHROMENO[3,4-C]PYRIDINES AND BENZO[C][1,7]NAPHTHYRIDIN-6-(5H)-ONES AS ADAPTOR ASSOCIATED KINASE 1 (AAK1) INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2019-05-22 | — | — | EP | disclosed |
| US-20190048006-A1 | BIARYL KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2019-02-14 | — | — | US | disclosed |
| EP-2799431-A1 | NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF | FUJIFILM Corporation (JP) | 2014-11-05 | — | — | EP | disclosed |
| US-20140309225-A1 | NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2014-10-16 | — | — | US | disclosed |
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NICOX SA (FR) | 2014-09-25 | — | — | US | disclosed |
| US-8796272-B2 | Glycine transporter-inhibiting substances | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20140179725-A1 | Aryl Ether-Base Kinase Inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2014-06-26 | — | — | US | disclosed |
| US-20140038999-A1 | Aryl Lactam Kinase Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2014-02-06 | — | — | US | disclosed |
| WO-2014022167-A1 | ARYL LACTAM KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-02-06 | — | — | WO | disclosed |
| US-20130331571-A1 | GLYCINE TRANSPORTER-INHIBITING SUBSTANCES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2013-12-12 | — | — | US | disclosed |
| WO-2013134036-A1 | ARYL ETHER-BASE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-09-12 | — | — | WO | disclosed |
| US-20100099729-A1 | NITRIC OXIDE DONOR COMPOUNDS | NICOX S.A. (FR) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406860-A1 | HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE | KRAS, NRAS, HRAS | ALDH1A1 1457/4885MME 4586/4885CNR1 3281/4885 |
| US-20140038999-A1 | Aryl Lactam Kinase Inhibitors | AAK1, ADCK1, ANKK1 | ALDH1A1 2563/4885MME 4167/4885CNR1 4029/4885 |
| US-20130331571-A1 | GLYCINE TRANSPORTER-INHIBITING SUBSTANCES | SLC1A2, SLC18A2, SLC6A1 | ALDH1A1 2122/4885MME 1519/4885CNR1 909/4885 |
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NOS3, NOS2, NOS1 | ALDH1A1 360/4885MME 870/4885CNR1 1094/4885 |
| US-20140179725-A1 | Aryl Ether-Base Kinase Inhibitors | AAK1, NCK1, ADCK1 | ALDH1A1 3028/4885MME 3834/4885CNR1 3126/4885 |
| US-10981910-B2 | Biaryl kinase inhibitors | AAK1, NCK1, MARCKS | ALDH1A1 3432/4885MME 3737/4885CNR1 4165/4885 |
| US-20100099729-A1 | NITRIC OXIDE DONOR COMPOUNDS | NOS3, NOS2, NOS1 | ALDH1A1 434/4885MME 1071/4885CNR1 1339/4885 |
| US-20210277001-A1 | BIARYL KINASE INHIBITORS | AAK1, NCK1, MARCKS | ALDH1A1 3432/4885MME 3737/4885CNR1 4165/4885 |
| US-20230219975-A1 | PYRIDO[2,3-B][1,4]OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4]OXAZEPINES AS IAP ANTAGONISTS | BIRC2, BIRC3, API5 | ALDH1A1 3253/4885MME 3551/4885CNR1 1957/4885 |
| US-20200317671-A1 | BIARYL KINASE INHIBITORS | AAK1, NCK1, MARCKS | ALDH1A1 3432/4885MME 3737/4885CNR1 4165/4885 |
| US-10544120-B2 | Biaryl kinase inhibitors | AAK1, CAMKK1, CAMKK2 | ALDH1A1 2360/4885MME 3682/4885CNR1 1433/4885 |
| US-20190048006-A1 | BIARYL KINASE INHIBITORS | AAK1, NCK1, MARCKS | ALDH1A1 3432/4885MME 3737/4885CNR1 4165/4885 |
| US-10351563-B2 | Biaryl kinase inhibitors | AAK1, NCK1, MARCKS | ALDH1A1 3432/4885MME 3737/4885CNR1 4165/4885 |
| US-20140309225-A1 | NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF | SYK, BTK, NOX4 | ALDH1A1 982/4885MME 3933/4885CNR1 821/4885 |
| US-10723734-B2 | Biaryl kinase inhibitors | AAK1, NCK1, MARCKS | ALDH1A1 3432/4885MME 3737/4885CNR1 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.